ID	Item	category	action	show	retrieve_from
1	My patient(s) were informed about the potential consequences of unexpected or incidental ﬁndings	Intention of the test and patient Information	bool	TRUE	FALSE
2	Opt-out: My patient(s) do NOT wish to be informed about unexpected and/or incidental findings	Intention of the test and patient Information	opt	TRUE	FALSE
3	Test purpose (Why is this test performed): 	Intention of the test and patient Information	purpose	TRUE	FALSE
4	Patient specifics	Intention of the test and patient Information	info	FALSE	Biological Sex,Age,Organism,Is Deceased?,Is Pregnant?
5	Disease specifics	Intention of the test and patient Information	info	FALSE	Case vs Control,Condition Under Study,Is Infection Suspected?,Infection Strain
5.1	Pathological diagnosis	Intention of the test and patient Information	patho	TRUE	FALSE
5.2	Disease stage	Intention of the test and patient Information	stage	TRUE	FALSE
5.3	Burden of disease	Intention of the test and patient Information	burden	TRUE	FALSE
5.4	Disease status	Intention of the test and patient Information	status	TRUE	FALSE
5.5	Previous and current oncological treatment	Intention of the test and patient Information	info	TRUE	Treatments
5.6	Previously diagnosed malignancies	Intention of the test and patient Information	bool	TRUE	FALSE
5.7	Conﬁrmed tumor predisposition	Intention of the test and patient Information	bool	TRUE	FALSE
5.8	Mutations from previous tissue or liquid proﬁling available	Intention of the test and patient Information	bool	TRUE	FALSE
5.9	Previously identiﬁed CH (clonal hematopoiesis)-related variants	Intention of the test and patient Information	info	TRUE	FALSE
6	Other relevant available clinical information	Intention of the test and patient Information	info	TRUE	Phenotypic features,Ethnicity
7	Sample QC 	Technical aspects – cfDNA sample	info	FALSE	FALSE
7.1	Sample Collection Date	Technical aspects – cfDNA sample	info	FALSE	FALSE
7.2	Sample Types	Technical aspects – cfDNA sample	info	FALSE	Sample Types
7.3	Material Anatomical Entity	Technical aspects – cfDNA sample	info	FALSE	Material Anatomical Entity
7.4	Cell Types	Technical aspects – cfDNA sample	info	FALSE	Cell Types
7.5	In vitro / In vivo	Technical aspects – cfDNA sample	info	FALSE	FALSE
7.6	Carrying Liquid Volume	Technical aspects – cfDNA sample	info	FALSE	FALSE
7.7	Carrying Liquid Volume Unit	Technical aspects – cfDNA sample	info	FALSE	FALSE
7.8	Macroscopic abnormalities (e.g. hemolysis)	Technical aspects – cfDNA sample	bool	TRUE	FALSE
7.9	Cell-free DNA isolation method	Technical aspects – cfDNA sample	info	FALSE	Extraction Kit (DNA Isolation Method)
7.1	DNA input mass	Technical aspects – cfDNA sample	info	FALSE	DNA Mass
7.11	DNA input mass units	Technical aspects – cfDNA sample	info	FALSE	DNA Mass Units
7.12	DNA profile	Technical aspects – cfDNA sample	dnavi	FALSE	plots/all_samples.pdf
7.13	DNA clustering	Technical aspects – cfDNA sample	dnavi	FALSE	plots/cluster_by_sample.pdf
7.14	Detection of high molecular weight DNA (Potential source: ecDNA, gDNA or orther)	Technical aspects – cfDNA sample	dnavi	FALSE	stats/peak_statistics.csv
7.15	Any sample QC not meeting criteria?	Technical aspects – cfDNA sample	bool	TRUE	FALSE
8	Downstream Test QC	Technical aspects – downstream test	info	FALSE	FALSE
8.1	Type of planned downstream assay	Technical aspects – downstream test	info	TRUE	FALSE
8.2	LOD (limit of detection)	Technical aspects – downstream test	info	TRUE	FALSE
8.3	LOB (limit of blank)	Technical aspects – downstream test	info	TRUE	FALSE
8.4	LOQ (limit of quantiﬁcation)	Technical aspects – downstream test	info	TRUE	FALSE
8.5	analytical sensitivity	Technical aspects – downstream test	info	TRUE	FALSE
8.6	analytical speciﬁcity	Technical aspects – downstream test	info	TRUE	FALSE
8.7	Sequencing: percentage of target region covered with the minimum required depth	Technical aspects – downstream test	info	TRUE	FALSE
8.9	Sequencing: average sequencing depth	Technical aspects – downstream test	info	TRUE	FALSE
8.1	Any downstream QC not meeting criteria?	Technical aspects – downstream test	bool	TRUE	FALSE
9	Variant QC 	Technical aspects – downstream test	info	FALSE	FALSE
9.1	Confirm: this report excludes variants with variant allele fraction (VAF) below or equal to the LOB.	Technical aspects – downstream test	disclaimer	TRUE	FALSE
9.2	Confirm: variants with VAF between LOB and LOD will be labeled ‘equivocal’ – their presence is uncertain	Technical aspects – downstream test	disclaimer	TRUE	FALSE
9.3	Recommendation for equivocal variants: (option corresponding tissue testing and/or liquid re-biopsy)	Technical aspects – downstream test	equivoc	TRUE	FALSE
9.4	Variant Report Option	Downstream test results	info	FALSE	FALSE
9.5	Pathogenic and likely pathogenic variants (incl. number of supporting reads, sequencing depth, VAF, number of mutated molecules, conﬁdence level)	Downstream test results	info	TRUE	FALSE
9.6	Variants in cancer susceptibility genes with VAF indicating germline origin (incl. number of supporting reads, sequencing depth, VAF, number of mutated molecules, conﬁdence level)	Downstream test results	info	TRUE	FALSE
9.7	Potential CH-related variants  (incl. number of supporting reads, sequencing depth, VAF, number of mutated molecules, conﬁdence level)	Downstream test results	info	TRUE	FALSE
9.8	Recommendation for putative germline variants: (option  genetic counselling and/or germline testing)	Downstream test results	germline	TRUE	FALSE
9.9	SCNA & fusions (LOD for SCNA and fusions may be lower compared to SNVs/indels; detection requires a higher tumor fraction)	Downstream test results	disclaimer	TRUE	FALSE
9.1	SCNA (estimated copy number or log2 ratio, conﬁdence level, potentially co-ampliﬁed genes and estimated size of the ampliﬁed/deleted segment)	Downstream test results	info	TRUE	FALSE
9.11	Negative results ( Tumor fraction – Not detected or Requested mutation is not detected)	Downstream test results	neg	TRUE	FALSE
9.12	Disclaimer – the presence of mutations below the LOD cannot be excluded.	Downstream test results	disclaimer	TRUE	FALSE
10	Unexpected findings	Unexpected findings	bool	FALSE	FALSE
10.1	Explanation why the ﬁndings were unexpected	Unexpected findings	explain	TRUE	FALSE
10.2	Recommendation for referral to a Molecular Tumor Board for discussion.	Unexpected findings	confirm	TRUE	FALSE
11	Clinically actionable results and evidence-based associations with response to speciﬁc drugs	Actionability	info	TRUE	FALSE
11.1	Disclaimer:The actual clinical annotation for matching a treatment to a speciﬁc variant for each individual patients should only be done by the treating physician or a Molecular Tumor Board (MTB).	Actionability	disclaimer	TRUE	FALSE
